HLB Therapeutics Co.,Ltd. (KOSDAQ:115450)

HLB Therapeutics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	6,179	17,934	23,709	45,821	99,873	13,930
Short-Term Investments	12,488	9,567	8,644	18,101	560	14,601
Trading Asset Securities	-	10,272	-	89.45	134.25	254.64
Cash & Short-Term Investments	18,667	37,773	32,353	64,012	100,567	28,786
Cash Growth	-59.77%	16.75%	-49.46%	-36.35%	249.37%	-40.21%
Accounts Receivable	17,323	8,626	9,497	7,900	6,448	4,391
Other Receivables	246.76	165.82	339.49	625.47	1,442	170.86
Receivables	17,570	8,792	9,837	8,527	8,874	5,617
Inventory	4,953	5,373	5,336	6,455	2,345	3,236
Prepaid Expenses	379.26	274.38	161.96	151.72	133.07	4.45
Other Current Assets	1,606	1,913	2,138	865.59	1,333	216
Total Current Assets	43,174	54,125	49,825	80,012	113,253	37,859
Property, Plant & Equipment	11,146	9,530	10,068	15,780	9,781	9,162
Long-Term Investments	65,767	61,804	58,608	20,335	3,715	15,382
Goodwill	-	5,388	5,388	1,075	382.08	4,826
Other Intangible Assets	86,670	5,399	4,896	4,260	3,925	3,918
Long-Term Deferred Charges	-	78,283	69,100	63,472	57,586	50,418
Other Long-Term Assets	4,572	5,264	2,910	2,709	1,070	372.3
Total Assets	211,328	219,793	200,795	187,643	189,711	121,938
Accounts Payable	4,773	4,817	8,183	2,517	1,272	2,877
Accrued Expenses	1,177	1,106	902.2	1,510	1,819	814.93
Short-Term Debt	21,500	17,531	7,436	51,551	50,441	12,949
Current Portion of Long-Term Debt	-	-	-	98	-	-
Current Portion of Leases	306.13	450.97	624.24	297.68	364.54	166.25
Other Current Liabilities	5,003	8,000	9,645	2,655	2,820	1,527
Total Current Liabilities	32,759	31,904	26,791	58,628	56,717	18,335
Long-Term Debt	4,470	5,170	1,840	48	-	-
Long-Term Leases	534.99	200.58	122.2	136.74	320.7	218.7
Other Long-Term Liabilities	238.1	194.81	194.81	194.81	194.81	194.81
Total Liabilities	38,002	37,925	29,276	59,528	59,672	21,632
Common Stock	42,191	40,070	37,016	15,992	15,668	13,475
Additional Paid-In Capital	86,945	136,440	125,176	97,290	190,850	145,207
Retained Earnings	15,434	-30,176	-4,862	-1,916	-90,644	-73,451
Treasury Stock	-1,298	-1,120	-483.65	-413.53	-413.53	-413.53
Comprehensive Income & Other	7,453	12,250	3,620	5,754	3,219	4,535
Total Common Equity	150,725	157,465	160,466	116,708	118,679	89,354
Minority Interest	22,601	24,404	11,053	11,408	11,360	10,952
Shareholders' Equity	173,326	181,868	171,519	128,116	130,039	100,306
Total Liabilities & Equity	211,328	219,793	200,795	187,643	189,711	121,938
Total Debt	26,811	23,353	10,022	52,131	51,126	13,334
Net Cash (Debt)	-8,145	14,420	22,330	11,881	49,441	15,451
Net Cash Growth	-	-35.42%	87.95%	-75.97%	219.98%	-
Net Cash Per Share	-96.50	174.09	286.72	174.61	805.53	270.01
Filing Date Shares Outstanding	83.98	83.74	77.39	34.42	69.79	59.93
Total Common Shares Outstanding	83.98	83.74	77.39	68.85	69.79	59.93
Working Capital	10,415	22,221	23,034	21,384	56,536	19,524
Book Value Per Share	1794.83	1880.38	2073.35	1695.21	1700.41	1490.96
Tangible Book Value	64,055	146,678	150,182	111,372	114,372	80,609
Tangible Book Value Per Share	762.77	1751.57	1940.48	1617.72	1638.70	1345.05
Land	4,544	4,429	4,429	5,916	4,429	4,429
Buildings	5,203	5,150	5,150	8,467	5,146	5,146
Machinery	2,803	2,838	2,927	10,253	2,737	2,396
Construction In Progress	1,442	-	-	263.3	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.